Dermatitis Treatments — Understanding Options in the U.S.

What dermatitis is

Dermatitis includes several types (atopic dermatitis, contact dermatitis, stasis dermatitis, among others) that produce dry, red, and often itchy skin. Atopic dermatitis is the most common form and frequently begins in childhood, although adults can be affected as well.

Typical symptoms

A dermatitis flare commonly causes itching, redness, dry or scaly skin, and sometimes oozing or crusting when the skin is broken. Symptoms can be localized or widespread and intensity varies between individuals. Flares may last days to weeks depending on triggers and treatment.

When to get help

Consult a primary-care clinician or dermatologist if symptoms are recurrent, severe, interfere with sleep or daily activities, or if skin changes suggest infection (increasing pain, spreading redness, pus). A clinician will take a medical history, look for triggers (allergens, irritants), and may order tests to rule out other causes.

Main treatment options

Topical therapies (applied to the skin)

• Emollients and moisturizers — Regular use of fragrance-free emollients helps restore the skin barrier and is a foundation of care.
• Topical corticosteroids — These remain a first-line anti-inflammatory option for flares; potency and duration are selected based on disease severity and body site
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — Non-steroidal topical anti-inflammatories useful for sensitive areas or steroid-sparing strategies.
• Topical JAK inhibitors — Newer topical agents have shown effectiveness in reducing signs and symptoms in clinical studies;

Systemic treatments (oral or injected medications)

• Conventional immunosuppressants — Agents such as cyclosporine, methotrexate, or azathioprine may be used in severe cases when topical therapies are insufficient; these require specialist supervision because of potential side effects.
• Biologic therapies — Monoclonal antibodies that target specific immune pathways (for example, dupilumab) have demonstrated efficacy for moderate-to-severe atopic dermatitis; prescribing information and safety summaries are available.
• Oral JAK inhibitors — Oral Janus kinase inhibitors show efficacy in trials but carry safety considerations; clinicians weigh benefits and risks when selecting therapy.

Phototherapy (light therapy)

Supervised ultraviolet (UV) phototherapy (narrowband UVB or UVA with psoralen where indicated) can be effective when topical treatments fail or are impractical; phototherapy is administered in clinics under dermatologist supervision.

Clinical trials available to schedule

Explore Mayo Clinic research testing new treatments, interventions, and diagnostic methods aimed at preventing, detecting, treating, or controlling this condition; trial listings include eligibility and scheduling details.

View Now

What to do during a flare (practical steps)

• Apply prescribed topical anti-inflammatory medication as directed.
• Use bland emollients frequently (after bathing and between medications) to help skin-barrier recovery.
• Avoid known irritants (harsh soaps, fragranced products) and use gentle skin-care products.
• Short-term wet-wrap therapy (under clinician guidance) may be used for extensive or severe flares to increase medication absorption and calm inflammation.

Preventing future flares — things to try

• Maintain regular moisturizing routines and gentle skin care.
• Identify and avoid triggers when possible (specific contact allergens, extreme temperatures, tobacco use).
• Structured behavioral and educational programs can improve self-management and adherence to treatment plans.
• Follow preventive and infection-control advice from clinicians, since skin barrier disruption increases infection risk.

Dermatitis in children and adolescents

Children with suspected dermatitis should receive timely assessment to confirm diagnosis, identify triggers, and initiate age-appropriate treatments. Many psychological and behavioral supports (education for caregivers, adherence strategies) form part of pediatric management. Biologics and newer topical agents have pediatric-specific data or approvals in certain age groups — clinicians tailor choices by age and severity.

Bottom line

Dermatitis is manageable with a stepwise approach that combines good skin care, trigger management, topical anti-inflammatory therapy, and escalation to phototherapy or systemic agents when indicated. Specialist referral and consideration of clinical trials may be appropriate for moderate-to-severe or treatment-resistant cases. Discuss options and safety considerations with a clinician to determine a treatment plan matched to individual needs.

Key references (click to read)

• https://my.clevelandclinic.org/health/diseases/4089-dermatitis
• https://www.mayoclinic.org/zh-hans/diseases-conditions/dermatitis-eczema/diagnosis-treatment/drc-20352386
• https://www.aad.org/public/diseases/eczema/types/atopic-dermatitis?
• https://www.mayoclinic.org/diseases-conditions/atopic-dermatitis-eczema/diagnosis-treatment/drc-20353279?
• https://www.mayo.edu/research/clinical-trials/diseases-conditions/atopic-dermatitis-%28eczema%29?
• https://nationaleczema.org/eczema/?
• https://www.cochrane.org/evidence/CD013356_what-best-way-use-topical-corticosteroids-treat-people-eczema?
• https://medlineplus.gov/eczema.html?
• https://pubmed.ncbi.nlm.nih.gov/37678577/